DEXCOM INC (DXCM) Stock Analyst Ratings
USA - NASDAQ:DXCM - US2521311074 - Common Stock
68.18 USD
-1.05 (-1.52%)
68.25 USD
+0.07 (+0.1%)
ChartMill assigns a Buy % Consensus number of 85% to DXCM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 104.5. This target is 53.27% above the current price.
DXCM was analyzed by 35 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about DXCM.
In the previous month the buy percentage consensus was at a similar level.
DXCM was analyzed by 35 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-21 | Stifel | Reiterate | Buy |
| 2025-10-15 | Truist Securities | Maintains | Buy -> Buy |
| 2025-10-07 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-01 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-09-29 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-09-26 | Baird | Maintains | Outperform -> Outperform |
| 2025-08-21 | Argus Research | Initiate | Buy |
| 2025-08-01 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-07-31 | UBS | Maintains | Buy -> Buy |
| 2025-07-31 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-07-31 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2025-07-31 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-07-30 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-16 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-07-15 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-06-16 | Truist Securities | Initiate | Buy |
| 2025-05-30 | Goldman Sachs | Initiate | Buy |
| 2025-05-22 | Citigroup | Maintains | Buy -> Buy |
| 2025-05-05 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-02 | Baird | Maintains | Outperform -> Outperform |
| 2025-05-02 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-05-02 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-04-10 | Mizuho | Initiate | Outperform |
| 2025-03-04 | Citigroup | Maintains | Buy -> Buy |
| 2025-02-14 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-02-14 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-03 | Redburn Atlantic | Upgrade | Neutral -> Buy |
| 2025-01-16 | Baird | Upgrade | Neutral -> Outperform |
| 2024-12-11 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-12-11 | Citigroup | Maintains | Buy -> Buy |
DEXCOM INC / DXCM FAQ
What do analysts expect the price target to be for DEXCOM INC (DXCM)?
35 analysts have analysed DXCM and the average price target is 104.5 USD. This implies a price increase of 53.27% is expected in the next year compared to the current price of 68.18.
What is the consensus rating for DXCM stock?
The consensus rating for DEXCOM INC (DXCM) is 84.5714 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed DEXCOM INC (DXCM)?
The number of analysts covering DEXCOM INC (DXCM) is 35.